­

Intended Use Means Different Things In Different Contexts

4 years ago by The IP Bloggers 0 comment
 Patent law can be confusing and complex.  There is deceptive attraction in simplifying intricate rules and doctrines into basic concepts that match the lay meaning of their labels.  Consider the issue of intended...
Continue Reading
PrevNext

When an Examiner Tells You Exactly The Wrong Procedure, Don't Be Lead Astray

4 years ago by The IP Bloggers 0 comment
 As discussed in a previous post (here), certain aspects can be addressed only by petition, whereas others can be addressed only by appeal to the board. Most of the time the demarcation is...
Continue Reading
Patent law has many rules that one might think overlap, but intertwining such things usually only leads to confusion. Even the Supreme Court gets caught mixing up issues as can be seen in...
Continue Reading

Dispensing with the Formalities: Ex Parte Quayle Actions

5 years ago by The IP Bloggers 0 comment
Checking my email after work one day, I was greeted with some unfortunate news: the application I was prosecuting had received yet another Office action.  Frustrated, I couldn’t resist skimming the substance of the...
Continue Reading

Star Wars and IP Strategy

5 years ago by The IP Bloggers 0 comment
The Star Wars franchise is a prime example of what a strong intellectual property strategy can do for a brand. They have developed a diverse portfolio over the years, leveraging their trademarks, patents,...
Continue Reading

Health Technology Collaborative - Oregon

6 years ago by The IP Bloggers 0 comment
A recent grant awarded by the Oregon Innovation Council of Business Oregon, makes possible a feasibility study to help the Health Technology Collaborative (HTC) discover what is needed to create a healthcare specific...
Continue Reading

35 U.S.C. §101 and Medical Diagnostics

6 years ago by The IP Bloggers 0 comment
U.S. Patent and Trademark Office Biotechnology, Chemical and Pharmaceutical Partnership Meeting During yesterday’s USPTO Biotechnology, Chemical and Pharmaceutical Partnership Meeting, the USPTO addressed two priorities of the USPTO Strategic Plan 2018-2022:                                 (1)...
Continue Reading

Disclaimer

“Disclaimer - Note that the views expressed herein do not represent the views of any law firm or client, and may not even represent the views of the author. This blog is NOT legal advice and is for informational purposes only. No attorney client relationship can be formed by reading this blog or using any of the information provided. The accuracy of the information provided has not been verified. ”